Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erica Pietroluongo

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Mediastinum (Hong Kong, China)|October 16, 2025
When rarity meets thoracic cancers: a narrative review from ITMIG 2024Margaret Ottaviano, Paolo Antonio Ascierto, Erica Pietroluongo
Lung Cancer (Amsterdam, Netherlands)|January 22, 2026
Immune-related disorders in patients with Thymic Epithelial Tumors: from pathogenesis to tailored interventionsErica Pietroluongo, Giovannella Palmieri, Paolo Antonio Ascierto, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|April 8, 2026
Less Is More, But Me-Too Should Not Be the Strategy for Lung Cancer Treatment in 2026Martina Bortolot, Stephanie P L Saw, Erica Pietroluongo, et al.
Scientific Reports|January 8, 2026
Serum HDL subfractions are impaired by COVID-19 vaccine in patients with thymic epithelial tumorsGustavo Cernera, Pietro De Placido, Erica Pietroluongo, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 22, 2025
Management of Autoimmune Conditions Associated With Thymic Epithelial TumorsWaqas Haque, Erica Pietroluongo, Juwairiyyah Fatima, et al.
Biomolecules|May 16, 2023
Glucocorticoid Receptor and Ovarian Cancer: From Biology to Therapeutic InterventionRoberto Buonaiuto, Giuseppe Neola, Sabrina Chiara Cecere, et al.
Clinical Chemistry and Laboratory Medicine|January 17, 2024
Serum biomarkers of inflammation and vascular damage upon SARS-Cov-2 mRNA vaccine in patients with thymic epithelial tumorsGustavo Cernera, Monica Gelzo, Pietro De Placido, et al.
Frontiers in Endocrinology|October 15, 2025
Diagnosis and treatment of paragangliomas and pheochromocytomas: a survey from the Italian Association for Neuroendocrine TumorsErica Pietroluongo, Antonella Lucia Marretta, Mauro Cives, et al.
JTO Clinical and Research Reports|January 26, 2026
Thymic Neuroendocrine Tumors: Evolving Insights and Innovative ApproachesErica Pietroluongo, Christine M Bestvina, Rachel Brattin, et al.
Cancers|February 15, 2022
The Never-Ending History of Octreotide in Thymic Tumors: A Vintage or A Contemporary Drug?Liliana Montella, Margaret Ottaviano, Rocco Morra, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Mediastinum (Hong Kong, China)|October 16, 2025
When rarity meets thoracic cancers: a narrative review from ITMIG 2024Margaret Ottaviano, Paolo Antonio Ascierto, Erica Pietroluongo
Lung Cancer (Amsterdam, Netherlands)|January 22, 2026
Immune-related disorders in patients with Thymic Epithelial Tumors: from pathogenesis to tailored interventionsErica Pietroluongo, Giovannella Palmieri, Paolo Antonio Ascierto, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|April 8, 2026
Less Is More, But Me-Too Should Not Be the Strategy for Lung Cancer Treatment in 2026Martina Bortolot, Stephanie P L Saw, Erica Pietroluongo, et al.
Scientific Reports|January 8, 2026
Serum HDL subfractions are impaired by COVID-19 vaccine in patients with thymic epithelial tumorsGustavo Cernera, Pietro De Placido, Erica Pietroluongo, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 22, 2025
Management of Autoimmune Conditions Associated With Thymic Epithelial TumorsWaqas Haque, Erica Pietroluongo, Juwairiyyah Fatima, et al.
Biomolecules|May 16, 2023
Glucocorticoid Receptor and Ovarian Cancer: From Biology to Therapeutic InterventionRoberto Buonaiuto, Giuseppe Neola, Sabrina Chiara Cecere, et al.
Clinical Chemistry and Laboratory Medicine|January 17, 2024
Serum biomarkers of inflammation and vascular damage upon SARS-Cov-2 mRNA vaccine in patients with thymic epithelial tumorsGustavo Cernera, Monica Gelzo, Pietro De Placido, et al.
Frontiers in Endocrinology|October 15, 2025
Diagnosis and treatment of paragangliomas and pheochromocytomas: a survey from the Italian Association for Neuroendocrine TumorsErica Pietroluongo, Antonella Lucia Marretta, Mauro Cives, et al.
JTO Clinical and Research Reports|January 26, 2026
Thymic Neuroendocrine Tumors: Evolving Insights and Innovative ApproachesErica Pietroluongo, Christine M Bestvina, Rachel Brattin, et al.
Cancers|February 15, 2022
The Never-Ending History of Octreotide in Thymic Tumors: A Vintage or A Contemporary Drug?Liliana Montella, Margaret Ottaviano, Rocco Morra, et al.
Pageof 4